Medico Remedies is a pharmaceutical formulation manufacturing company with manufacturing and marketing capabilities in formulation with focus on anti-infective, Beta-Lactums, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, haematinics and other supplements. Further in addition to the above, the company also has manufacturing and marketing capabilities in other drugs such as NSAIDS, antihistaminic, anti-diabetics, cardio vascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream & gel for various therapeutic segments.

The company was incorporated as Medico Remedies Private Limited on March 18, 1994 under the Companies Act, 1956 with the Registrar of Companies, Mumbai. The status of Company was changed to a public limited company and the name of Company was changed to Medico Remedies Limited by a special resolution passed on January 12, 2017. A fresh Certificate of Incorporation consequent upon conversion was issued on March 06, 2017 by the Registrar of Companies, Mumbai.

Business area of the company:

The company is engaged in manufacturing and selling of pharmaceutical formulation products in India. 

Products 

• Anti Biotics & Anti Infectives
• Beta-lactams- Penicillins
• Antifungals
• Miscellaneous
• Vitamins & Supplements
• Cardiovasculars
• Antipyretic, Analgesic, NSAIDs
• Antacid, Anti-Ulcer Drugs
• Antidepressants, Antipsychotics
• Antimalarials
• Dry Syrups
• Ointments & Creams
• Anti-Diabetics
• Syrups

Key Events and Milestones:

• 1994: Incorporated under Companies Act, 1956 as Medico Remedies Private Limited.
• 1999: Acquired plot at Palghar for setting up manufacturing set-up for general formulations. 
• 2002: Acquired plot at Palghar for setting up manufacturing set-up for beta lactam.
• 2016: Renewed WHO-GMP Certification for their manufacturing facility.
• 2016: Purchased corporate premises at ‘Hubtown Solaris’.
• 2017: Renewed ISO-9001:2015 Certification for their manufacturing facility.
• 2017: Converted into a public limited company and the name of company was changed to Medico Remedies Ltd.
• 2023: Completed its trial production rounds at the newly established state of the art ointment manufacturing plant at Palghar.
• 2025: Secured government supply order worth around Rs 16.31 crore to supply to Dominican Republic (PROMESE/CAL).
• 2025: Commenced work for new factory for manufacturing of B lactum tablets, capsules, dry syrup and injections (including amoxycillin and clauvulinic acid formulations).
• 2025: Secured government supply order worth around $1.78 million from the Main Pharmacy Association of the Ministry of Health and Medical Industry of Turkmenistan.
• 2026: Secured government supply order worth around Rs 37.17 crore from Uttar Pradesh Medical Supplies Corporation.